Navigating a new era of disease-modifying therapy: experiences, treatment preferences, and unmet expectations of family caregivers of Alzheimer’s patients receiving lecanemab in China

Authors

Institutions

Publication Details

Journal
BMC Geriatrics
Published
2026-10-16
DOI
https://doi.org/10.1186/s12877-026-08524-1
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Navigating a new era of disease-modifying therapy: experiences, treatment preferences, and unmet expectations of family caregivers of Alzheimer’s patients receiving lecanemab in China

Cheng Li, 易小江, 陈德芝, Yuhui Wang et al.
BMC Geriatrics
Alzheimer's disease research and treatments
article

Navigating a new era of disease-modifying therapy: experiences, treatment preferences, and unmet expectations of family caregivers of Alzheimer’s patients receiving lecanemab in China

Cheng Li, 易小江, 陈德芝, Yuhui Wang, Jing Huang, Yunrui Zhang, Yan Liang, Xiaoshuang Lu
article en

Abstract

No abstract available for this paper.
BMC Geriatrics
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Good health and well-being
Openalex Percentile: Top 13%
Alzheimer's disease research and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.